NO981386L - Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization - Google Patents

Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization

Info

Publication number: NO981386L
Authority: NO; Norway
Prior art keywords: stimulation; cell; immune responses; mediated immune; particular genetic
Prior art date: 1995-09-28

Application number

NO981386A

Other languages

Norwegian (no)

Other versions

NO981386D0 (en

Inventor

Louis D Falo Jr

Kenneth L Rock

Original Assignee

Univ Pittsburgh

Dana Farber Cancer Inst Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-09-28

Filing date

1998-03-26

Publication date

1998-05-28

1998-03-26 Application filed by Univ Pittsburgh, Dana Farber Cancer Inst Inc filed Critical Univ Pittsburgh

1998-03-26 Publication of NO981386D0 publication Critical patent/NO981386D0/en

1998-05-28 Publication of NO981386L publication Critical patent/NO981386L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
- A61K39/001192—Glycoprotein 100 [Gp100]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001102—Receptors, cell surface antigens or cell surface determinants
- A61K39/001103—Receptors for growth factors
- A61K39/001106—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ErbB4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001148—Regulators of development
- A61K39/00115—Apoptosis related proteins, e.g. survivin or livin
- A61K39/001151—Apoptosis related proteins, e.g. survivin or livin p53
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00118—Cancer antigens from embryonic or fetal origin
- A61K39/001182—Carcinoembryonic antigen [CEA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
- A61K39/001186—MAGE
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
- A61K39/001191—Melan-A/MART
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/19—Dendritic cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
- A61K40/24—Antigen-presenting cells [APC]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Oncology (AREA)
Immunology (AREA)
Mycology (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Developmental Biology & Embryology (AREA)
Reproductive Health (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO981386A 1995-09-28 1998-03-26 Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization NO981386L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53555695A	1995-09-28	1995-09-28
PCT/US1996/015728 WO1997011605A1 (en)	1995-09-28	1996-09-27	Stimulation of cell-mediated immune responses by targeted particulate genetic immunization

Publications (2)

Publication Number	Publication Date
NO981386D0 NO981386D0 (en)	1998-03-26
NO981386L true NO981386L (en)	1998-05-28

Family

ID=24134735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO981386A NO981386L (en)	1995-09-28	1998-03-26	Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization

Country Status (15)

Country	Link
EP (1)	EP0863704A4 (en)
JP (1)	JPH11512724A (en)
KR (1)	KR19990063672A (en)
CN (1)	CN1201369A (en)
AU (1)	AU716497B2 (en)
BG (1)	BG102355A (en)
CA (1)	CA2233278A1 (en)
CZ (1)	CZ92998A3 (en)
HU (1)	HUP9802651A3 (en)
NO (1)	NO981386L (en)
NZ (1)	NZ319891A (en)
PL (1)	PL325953A1 (en)
SK (1)	SK40198A3 (en)
TR (1)	TR199800573T2 (en)
WO (1)	WO1997011605A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997044446A1 (en) *	1996-05-24	1997-11-27	University Of Maryland At Baltimore	Dna vaccines for eliciting a mucosal immune response
TW570803B (en) *	1997-04-09	2004-01-11	Duphar Int Res	Influenza vaccine
US6287569B1 (en) *	1997-04-10	2001-09-11	The Regents Of The University Of California	Vaccines with enhanced intracellular processing
JP2002507392A (en) *	1998-02-11	2002-03-12	マキシジェン，インコーポレイテッド	Optimization of immunomodulatory properties of gene vaccines
EP1141314A2 (en)	1998-12-31	2001-10-10	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2370646A1 (en) *	1999-04-21	2000-10-26	Powderject Vaccines, Inc.	Nucleic acid immunization
JP4430868B2 (en) *	2001-03-30	2010-03-10	ジーエイチシーリサーチディベロップメントコーポレイション	Monocyte specific particulate delivery vehicle
JP5033303B2 (en)	2001-07-05	2012-09-26	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	Polynucleotides encoding polypeptides with antigenic type C HIV, polypeptides and uses thereof
US11529414B2 (en)	2020-06-23	2022-12-20	Orbis Health Solutions, Llc	Viral vaccines for in vivo expression of a nucleic acid encoding an immunogenic peptide and methods of using the same

1996
- 1996-09-27 CZ CZ98929A patent/CZ92998A3/en unknown
- 1996-09-27 PL PL96325953A patent/PL325953A1/en unknown
- 1996-09-27 EP EP96933987A patent/EP0863704A4/en not_active Withdrawn
- 1996-09-27 KR KR1019980702134A patent/KR19990063672A/en not_active Application Discontinuation
- 1996-09-27 CA CA002233278A patent/CA2233278A1/en not_active Abandoned
- 1996-09-27 AU AU72515/96A patent/AU716497B2/en not_active Ceased
- 1996-09-27 CN CN96198106A patent/CN1201369A/en active Pending
- 1996-09-27 SK SK401-98A patent/SK40198A3/en unknown
- 1996-09-27 NZ NZ319891A patent/NZ319891A/en unknown
- 1996-09-27 HU HU9802651A patent/HUP9802651A3/en unknown
- 1996-09-27 JP JP9513762A patent/JPH11512724A/en active Pending
- 1996-09-27 TR TR1998/00573T patent/TR199800573T2/en unknown
- 1996-09-27 WO PCT/US1996/015728 patent/WO1997011605A1/en not_active Application Discontinuation
1998
- 1998-03-26 BG BG102355A patent/BG102355A/en unknown
- 1998-03-26 NO NO981386A patent/NO981386L/en unknown

Also Published As

Publication number	Publication date
SK40198A3 (en)	1998-11-04
HUP9802651A3 (en)	2001-08-28
EP0863704A4 (en)	2003-09-10
JPH11512724A (en)	1999-11-02
TR199800573T2 (en)	1998-07-21
CA2233278A1 (en)	1997-04-03
CN1201369A (en)	1998-12-09
AU716497B2 (en)	2000-02-24
BG102355A (en)	1999-04-30
NO981386D0 (en)	1998-03-26
KR19990063672A (en)	1999-07-26
PL325953A1 (en)	1998-08-17
WO1997011605A1 (en)	1997-04-03
HUP9802651A2 (en)	1999-02-01
NZ319891A (en)	1999-01-28
CZ92998A3 (en)	1998-09-16
EP0863704A1 (en)	1998-09-16
AU7251596A (en)	1997-04-17

Publication	Publication Date	Title
ZA9811501B (en)	2000-06-15	Method to enhance an immune response of nucleic acid vaccination.
NO975730D0 (en)	1997-12-05	Method of increasing protective immune responses
NO964713D0 (en)	1996-11-07	DNA-based vaccination of fish by immersion
ZA961927B (en)	1997-09-08	Method of treating cardiac inflammatory disease.
NO961483D0 (en)	1996-04-12	Process for the treatment of oily formation
EP0831863A4 (en)	1999-01-13	Method of improving animal health
PL325522A1 (en)	1998-08-03	Method of obtaining spiorally coiled bristles
NO965107D0 (en)	1996-11-29	Copper-based catalysts, process for their preparation and use of the catalysts and process for the preparation of alkyl halogen silanes
NO981386L (en)	1998-05-28	Stimulation of Cell-Mediated Immune Responses by Targeted Particular Genetic Immunization
NO974089D0 (en)	1997-09-05	Stimulation of meiosis
NO986177D0 (en)	1998-12-29	Method of Preparation of Therapeutic DNA
ITBO940153A0 (en)	1994-04-12	METHOD FOR THE OPTICAL CONTROL OF PRODUCTS.
ITBO960142A0 (en)	1996-03-15	METHOD OF WRAPPING PRODUCTS
PT839001E (en)	2002-06-28	AROMATIZATION OF FOOD OILS
PL322580A1 (en)	1998-02-02	Method of obtaining nucleic acids
IT1268402B1 (en)	1997-02-27	AUTOMATIC SURFACE TREATMENT OF PRODUCTS
NO973193D0 (en)	1997-07-09	Collagen-based methods and formulations for the treatment of immune system-mediated diseases
ITMI950532A0 (en)	1995-03-17	AMINOTETRALIN DERIVATIVE FOR THE THERAPY OF CARDIOVASCULAR DISEASES
DE69320154D1 (en)	1998-09-10	Human id genes
KR960033768U (en)	1996-11-19	Hot wire fasteners of Schiropol cutter
KR970044493U (en)	1997-07-31	Safety net structure of fan heater
GB9503008D0 (en)	1995-04-05	Method of enhancing immune responses
NO20005987D0 (en)	2000-11-27	Process for the preparation of vinyl sulfoxides
IT235770Y1 (en)	2000-07-18	PRESENTER OF PRODUCTS FOR COMMERCIAL YEARS.
IL117305A0 (en)	1996-06-18	Gene therapy of atherosclerosis by genetically modified monocytes